(s)-2-((Tert-butoxycarbonyl)amino)-2-(4-methoxyphenyl)acetic acid, 95%, 500mg

(S)-2,2-Dimethyl-1-phenylpropan-1-amine hydrochloride, 95.0%, 250mg

tert-Butyl (1-(4-bromophenyl)propyl)carbamate, 97%, 100mg

(Methacryloxymethyl)methyldiethoxysilane, 25g

(9H-Fluoren-9-yl)methyl prop-2-yn-1-ylcarbamate, 97%, 25g

2-Mercaptopyridine>98.0%(HPLC)(T)100g

(S)-tert-butyl 2-(5-(4-chlorophenyl)-6,7-dimethyl-2-oxo-2,3-dihydro-1H-thieno[2,3-e][1,4]diazepin-3-yl)acetate, 98%, 500mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 100 ml, 90 mm, 1 Piece

(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-ylmethyl p-toluenesulfonate, 98.0%, 1g

1-(TERT-BUTOXYCARBONYL)-3-FLUOROPYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 250mg

2-(4-Bromo-2-chlorophenoxy)acetonitrile, 95.0%, 500mg

9,9-Bis[4-(2-hydroxyethoxy)phenyl]fluorene, >98.0%(GC), 1kg

2,6-Dibromoanthraquinone>95.0%(HPLC)1g